Comparison of Transient and Persistent Adverse Events After COVID-19 Vaccination: A Retrospective Analysis

Posted on | Posted on John Murphy | Leave a Comment on Comparison of Transient and Persistent Adverse Events After COVID-19 Vaccination: A Retrospective Analysis

Haruka Hikichi • Yuki Fujioka • Akiko Saga • Ken Watanabe • Ryo Hasegawa • Yuki Moritoki • Shigeharu Ueki, Published: June 28, 2024,DOI: 10.7759/cureus.63410 Peer-Reviewed Abstract Objective: Most reported adverse events following COVID-19 vaccination have been transient. However, persistent adverse events may occur with some frequency. This study aimed to analyze patient background characteristics and trends, with a focus on whether adverse events following COVID-19 vaccination were transient or […]

COVID-19 vaccine immune thrombosis and thrombocytopenia

Posted on | Posted on John Murphy | Leave a Comment on COVID-19 vaccine immune thrombosis and thrombocytopenia

What is VITT? Vaccine induced thrombosis and thrombocytopenia is a very rare immune condition, that leads to blood clotting and low platelets. Thrombosis: clots in the blood vessels blocking the flow of blood Thrombocytopenia: low platelets (small particles in the blood important for normal blood clotting)VITT episodes are serious and life-threatening. In this condition, blood […]

COVID-19 may damage corneal, lenticular transparency

Posted on | Posted on John Murphy | Leave a Comment on COVID-19 may damage corneal, lenticular transparency

Authors: Kalie VanDewater January 2022 Helio News Patients with a previously confirmed COVID-19 infection had significantly higher corneal and lenticular densitometric values compared with patients without a prior COVID-19 diagnosis, according to a prospective, cross-sectional study. “In addition to the determination of conjunctival abnormalities, the virus was also found to be present in both tears […]

Comprehensive Insights Into the Multi-faceted Manifestations of COVID-19: A Narrative Review

Posted on | Posted on John Murphy | Leave a Comment on Comprehensive Insights Into the Multi-faceted Manifestations of COVID-19: A Narrative Review

Abstract The emergence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and the ensuing COVID-19 pandemic had far-reaching and multifaceted effects on global health. This paper provides a comprehensive overview of the physical, extrapulmonary, and psychological manifestations associated with COVID-19. It highlights the wide-ranging impact of the virus on various organ systems, including the respiratory, cardiovascular, […]

Does COVID-19 Increase the Risk of Subsequent Kidney Diseases More Than Influenza? A Retrospective Cohort Study Using Real-World Data In the United States

Posted on | Posted on John Murphy | Leave a Comment on Does COVID-19 Increase the Risk of Subsequent Kidney Diseases More Than Influenza? A Retrospective Cohort Study Using Real-World Data In the United States

Yue Zhang, Nasrollah Ghahramani, Vernon M. Chinchilli, Djibril M. Badoi: https://doi.org/10.1101/2024.06.27.24309556 Abstract Background: Although case reports and observational studies suggest Coronavirus disease 2019 (COVID-19) increases the risk of kidney diseases, definitive real-world evidence, especially in comparison with influenza, is lacking. Our study aims to assess the association between COVID-19 infections and subsequent kidney diseases, using influenza as a positive control and incorporating a […]

COVID Paper Shows Declining Sperm Counts as a Result of Vaccines

Posted on | Posted on John Murphy | Leave a Comment on COVID Paper Shows Declining Sperm Counts as a Result of Vaccines

Authors:  Joe Hoft Published June 2022  A study of COVID vaccines shows that sperm counts in males are reduced as a result of taking the vaccine. Alex Berenson reported on a peer-reviewed paper published at the journal Andrology showing large decreases in sperm counts among men after the second dose of Pfizer’s mRNA Covid jab. Based on […]

Study identifies risk factors for long-haul COVID disease in adults

Posted on | Posted on John Murphy | Leave a Comment on Study identifies risk factors for long-haul COVID disease in adults

Researchers surveyed more than 3,000 adults over the age of 18 who were treated via Mayo Clinic’s virtual COVID-19 clinics in Florida, Arizona and Minnesota between March 2020 and March 2021. They reviewed the patients’ symptoms, the incidence of long-haul COVID in the group and how many were hospitalized due to COVID-19. The patients were […]

Long COVID patients report improvements following self-regulation therapy, study finds

Posted on | Posted on John Murphy | Leave a Comment on Long COVID patients report improvements following self-regulation therapy, study finds

by University of California, Los Angeles A new UCLA-led study suggests that some people living with long COVID may be able to alleviate certain symptoms by using short-term, self-regulating therapies. The small-scale study, published in the Journal of Psychosomatic Research, recruited a group of 20 long COVID patients, many of whom had been experiencing symptoms for more than […]

COVID’s Long Haul: Virus Lingers in Blood Years After Infection

Posted on | Posted on John Murphy | Leave a Comment on COVID’s Long Haul: Virus Lingers in Blood Years After Infection

Featured Neurology Neuroscience, March 7, 2024 Summary: SARS-CoV-2, the virus responsible for COVID-19, can persist in the blood and tissue of some patients for up to two years post-infection, offering new insights into the phenomenon of long COVID. This groundbreaking research found COVID antigens in blood samples up to 14 months after infection and in tissue […]

Study identifies potential cause of long COVID muscle weakness

Posted on | Posted on John Murphy | Leave a Comment on Study identifies potential cause of long COVID muscle weakness

by University of Malta University of Malta researchers have discovered a potential cause of the persistent and often debilitating symptoms experienced by long COVID-19 patients. The new study published in Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease has implications on the development of medications to treat individuals that have not completely recovered from COVID-19 infection. Nearly one […]